RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification

Chrispian Mamudi, Purnamawati, Panca Andana, Prayudi Santoso, Lidya Chaidir, Arto Soeroto · 2026

Read RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification by Chrispian Mamudi, Purnamawati, Panca Andana, Prayudi Santoso, Lidya Chaidir, Arto Soeroto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210066.txt.

Description

Chrispian Mamudi and co-authors review a six-gene blood signature that promises to follow tuberculosis through diagnosis, treatment, and danger. Tuberculosis still kills more people than any other single infection, partly because clinics lack fast ways to tell who is sick, who is worsening, and who is cured. Host gene signatures read the immune system's own report instead of hunting the bacterium. Their 2026 review weighs the RISK6 signature across those jobs.

The evidence, they find, is promising but fickle: the signature performs differently in different populations, and data in drug-resistant disease are thin. Read alone it will disappoint; read alongside microbiology and clinical signs, it earns its place. The authors resist both hype and dismissal, calling for validation in the varied real-world settings where the test would actually be used. The review is a translation manual between a neat laboratory signal and a messy clinic.

Catalog record

CREATORChrispian Mamudi, Purnamawati, Panca Andana, Prayudi Santoso, Lidya Chaidir, Arto Soeroto
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE70 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13210066

Browse the full library · About the Tower of Babel